This week’s contribution to ’52 Perspectives’ comes to us from Jim Worrell, CEO of Pharma Services Network, Inc. and Ameristart. Prior to Christopher Columbus’ voyage to the New World, many people thought the world was flat: Start sailing and you will eventually fall of the edge. Because no one had actually attempted to sail to [...]
{ 6 comments }
“Classifieds” for Pharmaceutical-outsourcing With the growing trend towards outsourcing and virtualization, the identification of suitable service and business partners has become a critical challenge. goBalto helps to accelerate drug development as it provides companies with an efficient tool to circumvent the time-consuming and expensive searching process. If you’re looking for a service provider, we now [...]
{ 0 comments }
A few months back I posted a summary on the dyamics of the Indian and Chinese pharmaceutical outsourcing market. Since many of goBalto’s users are searching for outsourcing services in these two regions, I was curious to see which region was more popular. Over the past 6 months, we have been using Google AdWords to [...]
{ 6 comments }
My colleague, Edwin Kim, and I attended the PharmAsia Summit in San Francisco hosted by Windhover. The event was filled with great discussions from key players in the pharma industry in emerging markets including the CEO of Dr. Reddy’s Laboratories and the VP and Head of R&D in Asia from Pfizer. I felt that the [...]
{ 4 comments }
Today we’re attending the ”Managed Outsourced Drug-Discovery” conference in the Claremont Resort and Spa, Berkeley, October 26. Outsourcing drug discovery presents a more nimble, less capital-intensive model that is rapidly growing and enhancing pharmaceutical research. With the ability to access diverse resources globally, comes the challenges of managing projects, data, and people in multiple time zones, [...]
{ 0 comments }
At goBalto, we’re all about increasing transparency on your pharmaceutical partners. China has become a hotbed of pharmaceutical outsourcing activity – particularly in the preclinical space. We partnered with an organization called ChinaBio led by Greg Scott. ChinaBio is a leading consultancy based in Shanghai assisting pharmaco seeking to gain insight into potential partners in [...]
{ 0 comments }
This week’s contribution to ’52 Perspectives’ comes to us from Dr. Umesh Dalvi, CEO at Orion Consulting Services. With more than 28 years at Bristol Myers Squibb in a variety of positions in US and overseas, Umesh brings a wealth of knowledge and hands-on experience to the table. Over the years he has built an [...]
{ 2 comments }
This week’s submission to ’52 Perspectives’ comes to us from Michael J.S. Thompson, Director of Business Development at Celltrion USA Inc., one of the world’s leading biologics contract manufacturing organizations for supply of clinical and commercial material 1. What are the ranges of development and manufacturing services Celltrion, Inc. offers the pharma/biopharma industry? Headquartered in [...]
{ 0 comments }
This week’s submission of “52 Perspectives” comes to us from Britton Jimenez, the Vice President of Business Development at Penn Pharma, a leading provider of fully integrated and cost effective pharmaceutical development and custom manufacturing services to the international healthcare industry. 1. What are the ranges of development and manufacturing services Penn Pharma offers the [...]
{ 2 comments }
This week’s submission of 52 Perspectives comes to us from Derek Hennecke. Derek is the CEO and Presidenct of Xcelience LLC, a Florida based contract manufacturer offering Formulation, Analytical & Stability, and Manufacturing services for the pharmaceutical industry. Derek provides us with his thoughts on what steps contract manufacturers should take to stand apart from [...]
{ 0 comments }
Copyright © 2011 goBalto All rights reserved.